Randomized controlled trial of mindfulness-based cancer recovery versus supportive expressive group therapy for distressed survivors of breast cancer (MINDSET)

Journal of Clinical Oncology

Volumn 31, Issue 25, 2013, Pages 3119-3126

  Carlson, Linda E ^a   Tamagawa, Rie ^a   Speca, Michael ^a   Faris, Peter ^b   Doll, Richard ^c   Stephen, Joanne ^c   Drysdale, Elaine ^c,d  

^a UNIVERSITY OF CALGARY   (Canada)

^b ALBERTA HEALTH SERVICES   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ADULT; ARTICLE; BREAST CANCER; CANCER SURVIVOR; CONTROLLED STUDY; EMOTION; FEMALE; GROUP THERAPY; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MINDFULNESS; MOOD; MOOD DISORDER; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SOCIAL SUPPORT; STRESS; STRESS MANAGEMENT; SUPPORT GROUP; SUPPORTIVE EXPRESSIVE GROUP THERAPY; ADAPTIVE BEHAVIOR; AGED; ALTERNATIVE MEDICINE; BLOOD; BREAST TUMOR; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; MEDITATION; MENTAL STRESS; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGICAL ASPECT; SURVIVOR; YOGA;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; HYDROCORTISONE; MEDITATION; MIDDLE AGED; MIND-BODY THERAPIES; PSYCHOTHERAPY, GROUP; STRESS, PSYCHOLOGICAL; SURVIVORS; YOGA;

EID: 84886534335     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.47.5210     Document Type: Article

References (50)

1. Ellison LF, Wilkins K: Canadian trends in cancer prevalence. Health Rep 23:7-16, 2012.
2. Ganz PA: Survivorship: Adult cancer survivors. Prim Care 36:721-741, 2009.
3. Mitchell AJ, Chan M, Bhatti H, et al: Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. Lancet Oncol 12:160-174, 2011.
4. Kabat-Zinn J: Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain and Illness. New York, NY, Delacourt, 1990.
5. Classen C, Diamond S, Soleman A, et al: Brief Supportive-Expressive Group Therapy for Women With Primary Breast Cancer: A Treatment Manual. Stanford, CA, Stanford University School of Medicine, 1993.
6. Carlson LE, Speca M: Mindfulness-Based Cancer Recovery: A Step-by-Step MBSR Approach to Help You Cope With Treatment and Reclaim Your Life. Oakville, CA, New Harbinger, 2010.
7. Carlson LE, Labelle LE, Garland SN, et al: Mindfulness-based interventions in oncology, in Didonna F (ed): Clinical Handbook of Mindfulness. New York, NY, Springer, 2009, pp 383-404.
8. Ledesma D, Kumano H: Mindfulness-based stress reduction and cancer: A meta-analysis. Psychooncology 18:571-579, 2009.
9. Matchim Y, Armer JM, Stewart BR: Mindfulness-based stress reduction among breast cancer survivors: A literature review and discussion. Oncol Nurs Forum 38:E61-E71, 2011.
10. Musial F, Bü ssing A, Heusser P, et al: Mindfulness-based stress reduction for integrative cancer care: A summary of evidence. Forsch Komplementmed 18:192-202, 2011.
11. Butler LD, Koopman C, Neri E, et al: Effects of supportive-expressive group therapy on pain in women with metastatic breast cancer. Health Psychol 28:579-587, 2009.
12. Classen CC, Kraemer HC, Blasey C, et al: Supportive-expressive group therapy for primary breast cancer patients: A randomized prospective multicenter trial. Psychooncology 17:438-447, 2008.
13. Grassi L, Sabato S, Rossi E, et al: Effects of supportive-expressive group therapy in breast cancer patients with affective disorders: A pilot study. Psychother Psychosom 79:39-47, 2010.
14. Kissane DW, Grabsch B, Clarke DM, et al: Supportive-expressive group therapy for women with metastatic breast cancer: Survival and psychosocial outcome from a randomized controlled trial. Psychooncology 16:277-286, 2007.
15. Sephton S, Spiegel D: Circadian disruption in cancer: A neuroendocrine-immune pathway from stress to disease? Brain Behav Immun 17:321-328, 2003.
16. Sephton SE, Sapolsky RM, Kraemer HC, et al: Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 92:994-1000, 2000.
17. Abercrombie HC, Giese-Davis J, Sephton S, et al: Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology 29: 1082-1092, 2004.
18. Carlson LE, Speca M, Patel KD, et al: Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology 29:448-474, 2004.
19. Lengacher CA, Kip KE, Barta M, et al: A pilot study evaluating the effect of mindfulness-based stress reduction on psychological status, physical status, salivary cortisol, and interleukin-6 among advanced-stage cancer patients and their caregivers. J Holist Nurs 30:170-185, 2012.
20. Brand S, Holsboer-Trachsler E, Naranjo JR, et al: Influence of mindfulness practice on cortisol and sleep in long-term and short-term meditators. Neuropsychobiology 65:109-118, 2012.
21. Matousek RH, Pruessner JC, Dobkin PL: Changes in the cortisol awakening response (CAR) following participation in mindfulness-based stress reduction in women who completed treatment for breast cancer. Complement Ther Clin Pract 17:65- 70, 2011.
22. Witek-Janusek L, Albuquerque K, Chroniak KR, et al: Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain Behav Immun 22:969-981, 2008.
23. Giese-Davis J, DiMiceli S, Sephton S, et al: Emotional expression and diurnal cortisol slope in women with metastatic breast cancer in supportiveexpressive group therapy: A preliminary study. Biol Psychol 73:190-198, 2006.
24. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: NCCN Practice Guidelines for the Management of Psychosocial Distress. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp.
25. Mitchell AJ: Short screening tools for cancerrelated distress: A review and diagnostic validity meta-analysis. J Natl Compr Canc Netw 8:487-494, 2010.
26. Kirschbaum C, Hellhammer DH: Salivary cortisol in psychoneuroendocrine research: Recent developments and applications. Psychoneuroendocrinology 19: 313-333, 1994.
27. Speca M, Carlson LE, Goodey E, et al: A randomized, wait-list controlled clinical trial: The effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med 62: 613-622, 2000.
28. Carlson LE, Ursuliak Z, Goodey E, et al The effects of a mindfulness meditation based stress reduction program on mood and symptoms of stress in cancer outpatients: Six month follow-up. Support Care Cancer 9:112-123, 2001.
29. Carlson LE, Speca M, Patel KD, et al: Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med 65:571-581, 2003.
30. Carlson LE, Garland SN: Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int J Behav Med 12:278-285, 2005.
31. Mackenzie MJ, Carlson LE, Munoz M, et al: A qualitative study of self-perceived effects of mindfulnessbased stress reduction (MBSR) in a psychosocial oncology setting. Stress Health 23:59-69, 2007.
32. Carlson LE, Brown KW: Validation of the Mindful Attention Awareness Scale in a cancer population. J Psychosom Res 58:29-33, 2005.
33. Birnie K, Garland SN, Carlson LE: Psychological benefits for cancer patients and their partners participating in mindfulness-based stress reduction (MBSR). Psychooncology 19:1004-1009, 2010.
34. Carlson LE, Speca M, Faris P, et al: One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain Behav Immun 21:1038-1049, 2007.
35. Antoni MH, Lechner S, Diaz A, et al: Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer. Brain Behav Immun 23:580-591, 2009.
36. McNair DA, Lorr M, Droppelman LF: Profile of Mood States. San Diego, CA, Educational and Industrial Testing Service, 1971.
37. Cassileth BR, Lusk EJ, Brown LL, et al: Psychosocial status of cancer patients and next of kin: Normative data from the profile of mood states. J Psychosoc Oncol 3:99-105, 1985.
38. Leckie MS, Thompson E: Symptoms of Stress Inventory. Seattle, WA, University of Washington, 1979.
39. Carlson LE, Thomas BC: Development of the Calgary Symptoms of Stress Inventory (C-SOSI). Int J Behav Med 14:249-256, 2007.
40. Brady MJ, Cella DF, Mo F, et al: Reliability and validity of the Functional Assessment of Cancer Therapy-Breast (FACT-B) quality-of-life instrument. J Clin Oncol 15:974-986, 1997.
41. Cella DF: Manual of the Functional Assessment of Cancer Therapy (FACT) Scales. Chicago, IL, Rush Presbyterian-St. Luke's Medical Center, 1996.
42. Sherbourne CD, Stewart AL: The MOS social support survey. Soc Sci Med 32:705-714, 1991.
43. Benjamini Y, Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B 57:289-300, 1995.
44. Perneger TV: What's wrong with Bonferroni adjustments. BMJ 316:1236-1238, 1998.
45. Mormon MC, Bogdan A, Cormont S, et al: Cortisol diurnal variation in blood and saliva of patients with metastatic colorectal cancer: Relevance for clinical outcome. Anticancer Res 22:1243-1249, 2002.
46. Lutgendorf SK, Weinrib AZ, Penedo F, et al: Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. J Clin Oncol 26:4820-4827, 2008.
47. Sephton SE, Lush E, Dedert EA, et al: Diurnal cortisol rhythm as a predictor of lung cancer survival. Brain Behav Immun 30:S163-S170, 2013 (suppl).
48. Cohen L, Cole SW, Sood AK, et al: Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: Role of inflammatory signaling. PLoS One 7:e42324, 2012.
49. Labelle LE, Campbell TS, Carlson LE: Mindfulness-based stress reduction in oncology: Evaluating mindfulness and rumination as mediators of change in depressive symptoms. Mindfulness 1:28-40, 2010.
50. Labelle LE: How does mindfulness-based stress reduction (MBSR) improve psychological functioning in cancer patients? [doctoral thesis] University of Calgary, Calgary, Alberta, Canada, 2012.